Drug-Resistant Infections
- PMID: 30212094
- Bookshelf ID: NBK525181
- DOI: 10.1596/978-1-4648-0524-0_ch18
Drug-Resistant Infections
Excerpt
The global rise in antibiotic resistance threatens to undo decades of progress in treating infectious diseases caused by bacterial pathogens (Laxminarayan and others 2006). Resistance to the drugs used to treat malaria, human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), and Mycobacterium tuberculosis is also a serious concern, with multidrug-resistant and extensively drug-resistant tuberculosis now documented worldwide, particularly in China, India, and the Russian Federation (WHO 2014). These diseases and their treatments are covered in depth in other chapters in this volume. This chapter deals specifically with antibiotic resistance in the One Health framework of humans, animals, and the environment.
© 2017 International Bank for Reconstruction and Development / The World Bank.
Sections
References
-
- Allegranzi B, Bagheri S, Nejad Combescure C, Graafmans W, Attar H, others. 2011. “Burden of Endemic Health-Care-Associated Infection in Developing Countries: Systematic Review and Meta-Analysis.” The Lancet 377 (9761): 228–41. - PubMed
-
- Allegranzi B, Pittet D. 2009. “Role of Hand Hygiene in Healthcare-Associated Infection Prevention.” Journal of Hospital Infection 73 (4): 305–15. - PubMed
-
- Australian Commission on Safety and Quality in Health Care . 2013. “Australian One Health Antimicrobial Resistance Colloquium.” Australian Commission of Safety and Quality in Health Care, Canberra.
Publication types
LinkOut - more resources
Full Text Sources